NextCure, Inc.NXTCNASDAQ

Revenue (LTM)

Net Income (LTM)

$-56M

-0.3% YoY

Free Cash Flow

$-50M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-2
Operating Income	-71	-76↓7.3%	-68↑10.9%	-60↑11.7%	-58↑3.6%
Net Income	-69	-75↓7.7%	-63↑16.1%	-56↑11.3%	-56↓0.3%
EBITDA	-67	-72↓7.8%	-64↑10.9%	-54↑15.0%	-55↓2.0%
EPS Diluted	-30.15	-32.32↓7.2%	-27.04↑16.3%	-23.88↑11.7%	-19.65↑17.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	12	27↑115.9%	13↓50.9%	28↑111.9%	26↓6.3%
Total Current Assets	228	164↓28.0%	113↓31.3%	72↓36.3%	44↓39.1%
Total Assets	242	184↓24.0%	128↓30.5%	81↓36.8%	50↓37.9%
Total Current Liabilities	7	9↑38.1%	7↓24.6%	10↑39.1%	11↑10.4%
Total Liabilities	9	17↑84.8%	14↓18.1%	15↑13.0%	15↓1.0%
Total Equity	233	168↓28.2%	114↓31.7%	65↓42.8%	35↓46.6%
Total Debt	0	7	7↓7.3%	6↓9.9%	4↓30.3%
Net Debt	-12	-20↓58.1%	-6↑66.8%	-22↓236.2%	-22↓0.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-57	-54↑5.9%	-53↑1.7%	-41↑23.0%	-50↓21.6%
Capital Expenditure	-2	-2↑10.3%	-1↑61.2%	-0↑42.2%	0
Free Cash Flow	-60	-56↑6.0%	-54↑3.9%	-41↑23.3%	-50↓20.2%
Stock-Based Comp	10	10↓7.6%	8↓13.9%	6↓22.6%	3↓52.9%
Net Change in Cash	-24	14↑159.8%	-14↓194.8%	15↑208.1%	-2↓111.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance